Second amended complaint filed in case over Lantus
MLex Summary: FWK Holdings and César Castillo have filed a second amended complaint accusing Sanofi of unlawfully barring market entry of a generic version of its branded long-acting insulin analogue drug...To view the full article, register now.
Already a subscriber? Click here to view full article